The company needs financing conditions to remain agreeable, and there needs to be continued investor demand for the firm’s convertible debt, the report said.Markets, news, Bitcoin, Analysts, CoinShares, MSTR, MicroStrategyRead More
You might also be interested in reading Exact Sciences sees 13% screening growth in 2025 with new diagnostics launches.